Sponsor Dossier
Gedeon Richter
Sponsor Dossier for Gedeon Richter. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AFOLIA
- Brand: BEMFOLA
- Brand: CYCLOGEST
- Brand: GANIRELIX
- Brand: POSTINOR-1
- Brand: RYEQO
- Brand: TERROSA
- Device (sponsor): Prefilled self-injector, single-dose
- Device (sponsor): Prefilled self-injector, single-dose
- Device (sponsor): Basic insulin pen, replaceable-cartridge
- Device (sponsor): Basic insulin pen, replaceable-cartridge
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Needle, injector, medication/vaccine
About
Gedeon Richter is an Australian Private Company with ABN 98 602 550 274, registered in New South Wales. The company is active and GST-registered.
Portfolio
Gedeon Richter has seven brands on the ARTG, with six cleared the SEO quality gate as indexable brands. Five brands have Product Information on file, two are PBS-listed, four have PBAC outcomes on record, and two have AusPARs on record. Notable brands include AFOLIA, BEMFOLA, CYCLOGEST, GANIRELIX, POSTINOR-1, RYEQO, and TERROSA.
Therapeutic focus —
Reproductive Health (3 brands) — Women's Health (3 brands) — Endocrinology (1 brand)
PBS footprint
Two of Gedeon Richter's brands have PBS-listed items, with the portfolio's latest PBS schedule date being 1 May 2026.
Regulatory activity
Gedeon Richter's most recent PBAC outcome dates from 1 November 2024, with four brands holding PBAC outcomes on record. The most recent AusPAR is dated 25 November 2015, with two brands holding AusPARs on record.